“Antibiotics are used to eliminate bacteria that cause dangerous infectious diseases. It is an extremely powerful tool, the basis of modern medicine. However, nature is constantly changing and bacteria are also adapting to become resistant to antibiotics. Today this is no longer an isolated phenomenon. These “superbugs” are already one of the main causes of death worldwide. If left unchecked, by 2050 they will kill more people than cancer does today.” Alexandros Pantalis, CEO of Phagos.
In fact, resistant bacteria have been identified as one of the top threats to global health over the next few years by the World Health Organization, the European Commission, the Centers for Disease Control and Prevention, and Health Canada, among others.
Phagos is developing a solution based on culture of the natural predator of bacteria, the bacteriophage (commonly called phage).
“Phages are microorganisms that can evolve to adapt to new bacteria and eliminate them with great efficiency. At Phagos, we use their evolutionary potential to develop dynamic therapies and regulate bacterial populations with high precision and over the long term,” he adds Adele James, PhD, CTO of Phagos.
Award-winning entrepreneur. Baconaholic. Food advocate. Wannabe beer maven. Twitter ninja.
